These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34122606)

  • 1. Moxibustion Protects Dopaminergic Neurons in Parkinson's Disease through Antiferroptosis.
    Huang Z; Si W; Li X; Ye S; Liu X; Ji Y; Hao X; Chen D; Zhu M
    Evid Based Complement Alternat Med; 2021; 2021():6668249. PubMed ID: 34122606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxibustion Exerts a Neuroprotective Effect through Antiferroptosis in Parkinson's Disease.
    Lu J; Liu X; Tian Y; Li H; Ren Z; Liang S; Zhang G; Zhao C; Li X; Wang T; Chen D; Kuang W; Zhu M
    Evid Based Complement Alternat Med; 2019; 2019():2735492. PubMed ID: 31467572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxibustion improves motor function by down-regulating SNX5 and inhibiting ferroptosis in neurons of corpus striatum in mice with Parkinson's disease.
    Gao D; Li QL; Wang QZ; Wu CX; Hao XQ; Wang XL; Li MZ; Zhao LJ; Zhu ML
    Zhen Ci Yan Jiu; 2024 Jul; 49(7):736-742. PubMed ID: 39020492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR‑335 promotes ferroptosis by targeting ferritin heavy chain 1 in
    Li X; Si W; Li Z; Tian Y; Liu X; Ye S; Huang Z; Ji Y; Zhao C; Hao X; Chen D; Zhu M
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
    Zeng X; An H; Yu F; Wang K; Zheng L; Zhou W; Bao Y; Yang J; Shen N; Huang D
    Neurochem Res; 2021 May; 46(5):1239-1251. PubMed ID: 33646533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect and mechanism of moxibustion on oxidative stress injury in rats with Parkinson's disease by activating Nrf2/ARE pathway].
    Liu XL; Lu J; Tian Y; Zhang GY; Zhao CP; Wang TT; Li XR; Zhu ML
    Zhongguo Zhen Jiu; 2020 Aug; 40(8):857-62. PubMed ID: 32869595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson's disease.
    Zheng Q; Ma P; Yang P; Zhai S; He M; Zhang X; Tu Q; Jiao L; Ye L; Feng Z; Zhang C
    Neurosci Lett; 2023 Jul; 810():137346. PubMed ID: 37308056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of p62-Keap1-Nrf2 Pathway Protects 6-Hydroxydopamine-Induced Ferroptosis in Dopaminergic Cells.
    Sun Y; He L; Wang T; Hua W; Qin H; Wang J; Wang L; Gu W; Li T; Li N; Liu X; Chen F; Tang L
    Mol Neurobiol; 2020 Nov; 57(11):4628-4641. PubMed ID: 32770451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways.
    Zhang J; Niu N; Wang M; McNutt MA; Zhang D; Zhang B; Lu S; Liu Y; Liu Z
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1911-20. PubMed ID: 23791745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease.
    Levivier M; Przedborski S; Bencsics C; Kang UJ
    J Neurosci; 1995 Dec; 15(12):7810-20. PubMed ID: 8613721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hippocampal neuronal ferroptosis involved in cognitive dysfunction in rats with sepsis-related encephalopathy through the Nrf2/GPX4 signaling pathway].
    Yao P; Chen Y; Li Y; Zhang Y; Qi H; Xu W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Nov; 31(11):1389-1394. PubMed ID: 31898571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Zn
    Tamano H; Nishio R; Morioka H; Takeda A
    Mol Neurobiol; 2019 Jan; 56(1):435-443. PubMed ID: 29705946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
    Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
    Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soot nanoparticles promote ferroptosis in dopaminergic neurons via alteration of m6A RNA methylation in Parkinson's disease.
    Feng J; Zhang P; Chen K; Huang P; Liang X; Dong J; Zhu B; Fu Z; Deng T; Zhu L; Chen C; Zhang Y
    J Hazard Mater; 2024 Jul; 473():134691. PubMed ID: 38788584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione peroxidase 4 participates in secondary brain injury through mediating ferroptosis in a rat model of intracerebral hemorrhage.
    Zhang Z; Wu Y; Yuan S; Zhang P; Zhang J; Li H; Li X; Shen H; Wang Z; Chen G
    Brain Res; 2018 Dec; 1701():112-125. PubMed ID: 30205109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of Rapid Influx of Extracellular Zn
    Tamano H; Morioka H; Nishio R; Takeuchi A; Takeda A
    Mol Neurobiol; 2019 Jun; 56(6):4539-4548. PubMed ID: 30341553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of moxibustion on mTOR-mediated autophagy in rotenone-induced Parkinson's disease model rats.
    Wang SJ; Wang Q; Ma J; Yu PH; Wang ZM; Wang B
    Neural Regen Res; 2018 Jan; 13(1):112-118. PubMed ID: 29451215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
    Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
    Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron toxicity, ferroptosis and microbiota in Parkinson's disease: Implications for novel targets.
    Carvalho FV; Landis HE; Getachew B; Silva VDA; Ribeiro PR; Aschner M; Tizabi Y
    Adv Neurotoxicol; 2024; 11():105-132. PubMed ID: 38770370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson's disease.
    Mishra A; Singh S; Tiwari V; Bano S; Shukla S
    Behav Brain Res; 2020 Jan; 378():112304. PubMed ID: 31626851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.